nucynta extended-release tablet (extended-release)
endo ventures ltd. - tapentadol (tapentadol hydrochloride) - tablet (extended-release) - 100mg - tapentadol (tapentadol hydrochloride) 100mg - opiate agonists
nucynta extended-release tablet (extended-release)
endo ventures ltd. - tapentadol (tapentadol hydrochloride) - tablet (extended-release) - 150mg - tapentadol (tapentadol hydrochloride) 150mg - opiate agonists
nucynta extended-release tablet (extended-release)
endo ventures ltd. - tapentadol (tapentadol hydrochloride) - tablet (extended-release) - 200mg - tapentadol (tapentadol hydrochloride) 200mg - opiate agonists
nucynta extended-release tablet (extended-release)
endo ventures ltd. - tapentadol (tapentadol hydrochloride) - tablet (extended-release) - 250mg - tapentadol (tapentadol hydrochloride) 250mg - opiate agonists
palexia 50 mg film-coat. tabl.
grunenthal sa-nv - tapentadol hydrochloride 58,24 mg - eq. tapentadol 50 mg - film-coated tablet - 50 mg - tapentadol hydrochloride 58.24 mg - tapentadol
palexia 75 mg film-coat. tabl.
grunenthal sa-nv - tapentadol hydrochloride 87,36 mg - eq. tapentadol 75 mg - film-coated tablet - 75 mg - tapentadol hydrochloride 87.36 mg - tapentadol
palexia 100 mg film-coat. tabl.
grunenthal sa-nv - tapentadol hydrochloride 116,48 mg - eq. tapentadol 100 mg - film-coated tablet - 100 mg - tapentadol hydrochloride 116.48 mg - tapentadol
palexia 20 mg/ml or. sol.
grunenthal sa-nv - tapentadol hydrochloride 23,3 mg/ml - eq. tapentadol 20 mg/ml - oral solution - 20 mg/ml - tapentadol hydrochloride 23.3 mg/ml - tapentadol
palexia 4 mg/ml or. sol.
grunenthal sa-nv - tapentadol hydrochloride 4,66 mg/ml - eq. tapentadol 4 mg/ml - oral solution - 4 mg/ml - tapentadol hydrochloride 4.66 mg/ml - tapentadol
palexia retard 50 mg tabl. prol.-rel.
grunenthal sa-nv - tapentadol hydrochloride 58,24 mg - eq. tapentadol 50 mg - prolonged-release tablet - 50 mg - tapentadol hydrochloride 58.24 mg - tapentadol